Direkt zum Inhalt
Merck
  • SYLARAS: A Platform for the Statistical Analysis and Visual Display of Systemic Immunoprofiling Data and Its Application to Glioblastoma.

SYLARAS: A Platform for the Statistical Analysis and Visual Display of Systemic Immunoprofiling Data and Its Application to Glioblastoma.

Cell systems (2020-09-09)
Gregory J Baker, Jeremy L Muhlich, Sucheendra K Palaniappan, Jodene K Moore, Stephanie H Davis, Sandro Santagata, Peter K Sorger
ZUSAMMENFASSUNG

Accurately profiling systemic immune responses to cancer initiation and progression is necessary for understanding tumor surveillance and, ultimately, improving therapy. Here, we describe the SYLARAS software tool (systemic lymphoid architecture response assessment) and a dataset collected with SYLARAS that describes the frequencies of immune cells in primary and secondary lymphoid organs and in the tumor microenvironment of mice engrafted with a standard syngeneic glioblastoma (GBM) model. The data resource involves profiles of 5 lymphoid tissues in 48 mice and shows that GBM causes wide-spread changes in the local and systemic immune architecture. We use SYLARAS to identify a subset of CD45R/B220+ CD8+ T cells that is depleted from circulation but accumulates in the tumor mass and confirm this finding using multiplexed immunofluorescence microscopy. SYLARAS is freely available for download at (https://github.com/gjbaker/sylaras). A record of this paper's transparent peer review process is included in the Supplemental Information.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumchlorid, ACS reagent, ≥99.0%
Sigma-Aldrich
D-(+)-Glukose, ≥99.5% (GC)
Sigma-Aldrich
Natriumphosphat, einbasisch Dihydrat, BioUltra, for molecular biology, ≥99.0% (T)
Sigma-Aldrich
Ethylendiamintetraessigsäure Dinatriumsalz Dihydrat, reagent grade, 98.5-101.5% (titration)
Sigma-Aldrich
Kaliumchlorid, BioXtra, ≥99.0%
Sigma-Aldrich
Heparin Natriumsalz aus Schweinedarm, ≥180 USP units/mg
Sigma-Aldrich
Calciumchlorid Dihydrat
Sigma-Aldrich
4-Chlorphenyl-2-bromethylether, 98%